In this study we divided lung cancer samples into high and low PER1 mRNA and PER1 protein expression cohorts and observed lower hypoxia scores in tumors with higher expression of PER1 mRNA or PER1 protein, the same cohort that is enriched for poorly prognostic STK11 mutations and low PD-L1 expression. The gene discussed is CD274; the disease is lung cancer.